404
Participants
Start Date
August 31, 2004
pVGI.1(VEGF2)
New York Presbyterian Hospital, New York
Columbia Presbyterian, New York
University of Rochester, Rochester
Washington Heart, Washington D.C.
Medstar Research, Towson
Durham VA Medical Center, Durham
Crawford Long Hospital, Atlanta
Fuqua Heart Center of Piedmont Hospital, Atlanta
St. Joseph Hospital of Atlanta, Atlanta
Shands Hospital - Jacksonville, FL, Jacksonville
Cardiology, P.C., Birmingham
Baptist Hospital of East Tennessee, Knoxville
The Care Group, LLC, Indianapolis
Borgess Research Institute, Kalamazoo
Midwest CV Research Foundation, Davenport
Heart Care Milwaukee, WI, Milwaukee
Minneapolis Heart Institute, Minneapolis
Mayo Clinic Hospital/Rochester, Rochester
Midwest Heart Foundation, Lombard
Evanston Northwestern Healthcare, Evanston
Rush University Medical Center, Chicago
Prairie Cardiovascular, Springfield
Nebraska Heart Institute, Lincoln
Oklahoma Cardiovascular Research, Oklahoma City
Baylor University Hospital, Dallas
Cardiovascular Associates of East Texas, Tyler
Texas Heart Institute, Houston
The Methodist Hospital, Houston
Aurora Denver Cardiology Associates, Aurora
Arizona Heart Institute, Phoenix
Mayo Clinic Hospital/Scottsdale, Phoenix
Scripps Green Medical Center, La Jolla
Swedish Medical Center, Seattle
Caritas St. Elizabeth's Medical Center, Boston
Fletcher Allen Healthcare, Burlington
Lead Sponsor
Corautus Genetics
INDUSTRY